Article
Multicenter Evaluation of a Novel Automated Rapid Detection System of BRAF Status in Formalin-Fixed, Paraffin-Embedded Tissues.
The Journal of molecular diagnostics : JMD - 1 May 2016
Schiefer Ana-Iris, Parlow Laura, Gabler Lisa, Mesteri Ildiko, Koperek Oskar, von Deimling Andreas, Streubel Berthold, Preusser Matthias, Lehmann Annika, Kellner Udo, Pauwels Patrick, Lambin Suzan, Dietel Manfred, Hummel Michael, Klauschen Frederick, Birner Peter, Möbs Markus
Abstract excerpt
The mutated BRAF oncogene represents a therapeutic target in malignant melanoma. Because BRAF mutations are also involved in the pathogenesis of other human malignancies, the use of specific BRAF inhibitors might also be extended to other diseases in the future. A prerequisite for the clinical application of BRAF inhibitors is the reliable detection of activating BRAF mutations in routine histopathological...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
